DiaMedica Therapeutics Inc. (DMAC)

Oncternal Therapeutics Revenue

• Revenue (ttm): n/a
• Revenue Growth: n/a
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: 28
• Market Cap: 310.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.